Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.12 USD | -0.82% | -2.70% | -11.35% |
May. 07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
May. 07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.35% | 1.92B | |
+51.49% | 63.85B | |
-2.32% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.70% | 26.52B | |
-21.57% | 18.69B | |
+2.84% | 12.73B | |
+22.04% | 12.11B | |
+27.83% | 12.07B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Cantor Fitzgerald Lowers Price Target on Beam Therapeutics to $32 From $56, Maintains Overweight Rating